Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab + CHOP vs CHOP in Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma
NCT00004112Phase 3Completed
- Sponsor
- University of Nebraska
- Start
- Sep 1999
- Primary completion
- Dec 2000
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in non-Hodgkin lymphoma (NHL), sponsored by University of Nebraska. Started Sep 1999; status: completed.
02
Drugs
rituximab
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00004112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004112.